$CAMP

$3.65 +$0.44 (13.71%) Close

$CAMP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 62.8M shares outstanding

Who owns CAMP?

By type of holder

Institutions 66.4% Insiders 25.8% Everyone else 7.8%

Concentration Top 10 holders own 78.3%

Andrew J. Schwab 10.2% · Kush Parmar 10.2%

Institutional ownership

66.4%

+3.0 pts vs last qtr

Institutional holders

+15 vs last qtr

Net shares bought

+1.9M

by institutions in Q2 2026

New / sold out

23 / 8

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +6.3M
BlackRock, Inc. +1.2M

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −6.3M
Enavate Sciences GP, LLC −765.4K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for CAMP4 Therapeutics Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+547.8%

+547.76% a year

Each share's claim on the business

−84.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $8.03M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years49% Under 1 year51%

Quarterly turnover

22.1%

of institutional shares changed hands

Top 10 managers, median time held

1.5 years

Super Investors

Investment managers reporting CAMP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
JT Jupiter Topco LLC	6.3M	10.05%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding6.3M (Q2'26) Change over 8 quarters+6.3M Share of the company10.050% Jupiter Topco LLC's full portfolio →
JH Janus Henderson Group PLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding6.3M (Q4'25) Change over 8 quarters0 Janus Henderson Group PLC's full portfolio →

Jupiter Topco LLC

6.3M

% of company

10.05%

Change vs last qtr

NEW

Held since

Q2 '26

Janus Henderson Group PLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

28 more super investors behind a free account

See every manager holding CAMP4 Therapeutics Corp, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CAMP on Form N-PORT; together they hold 8.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SB Select Biotechnology Portfolio Fidelity Select Portfolios	$5.25M	1.3M	2.11%	0.08%	August 31, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$4.98M	1.1M	1.82%	0.00%	June 30, 2026

Select Biotechnology Portfolio

Fidelity Select Portfolios

Position value

$5.25M

% of company

2.11%

% of the fund

0.08%

As of

August 31, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$4.98M

% of company

1.82%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding CAMP4 Therapeutics Corp and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AJ Andrew J. Schwab 5%+ holder 13D · 9.9%	6.4M	10.17%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.170% Disclosed stake13D · 9.9% View the 13D/G filing →
KP Kush Parmar 5%+ holder 13D · 9.9%	6.4M	10.15%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.150% Disclosed stake13D · 9.9% View the 13D/G filing →

Andrew J. Schwab

5%+ holder13D · 9.9%

6.4M

% of company

10.17%

Change vs last qtr

—

Held since

—

Kush Parmar

5%+ holder13D · 9.9%

6.4M

% of company

10.15%

Change vs last qtr

—

Held since

—

20 more holders behind a free account

See every insider and 5%+ holder of CAMP4 Therapeutics Corp.

Comments